Skip to main content

Colitis News

Related terms: Enteritis, Noninfectious

CutisPharma Announces FDA Approval of Firvanq (vancomycin) for Treatment of Clostridium Difficile Associated Diarrhea and Staphylococcus Aureus Colitis

WILMINGTON, Mass. (Jan. 29, 2018) – CutisPharma announced today that the US Food and Drug Administration (FDA) has approved Firvanq (vancomycin hydrochloride) for oral solution, for the treatment of C...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Ulcerative Colitis, Gastrointestinal Disorders